Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.21.2
Balance Sheets - USD ($)
Mar. 31, 2021
Jun. 30, 2020
Current assets:    
Cash and cash equivalents $ 3,307,083 $ 3,024,980
Receivable - related party 3,500
Prepaid expenses and other current assets 591,662
Total current assets 3,898,745 3,028,480
Deferred offering costs 392,730
Total assets 4,291,475 3,028,480
Current liabilities:    
Accounts payable 82,027
Accrued expenses 211,139 22,579
Promissory notes - related party 201,286
Total current liabilities 293,166 223,865
Warrant liability 10,458,393
Total Liabilities 10,751,559 223,865
Commitments and contingencies
Series A convertible preferred stock, $0.0001 par value; 8,943,906 shares authorized; 2,047,500 shares issued and outstanding at March 31, 2021 and June 30, 2020 2,975,752 2,975,752
Stockholders' deficit:    
Common stock, $0.001 par value; 22,800,000 shares authorized; 12,982,500 and 12,000,000 shares issued and outstanding at March 31, 2021 and June 30, 2020, respectively 12,983 12,000
Additional paid-in capital 83,526
Accumulated deficit (9,532,345) (183,137)
Total stockholders' deficit (9,435,836) (171,137)
Total liabilities, convertible preferred stock, and stockholders' deficit $ 4,291,475 $ 3,028,480